Looking ahead with courage and optimism: A look back at the "IHK-Heimspiel"
Football and entrepreneurship - this was the motto of the IHK home game, the annual conference of the IHK Südlicher Oberrhein, for which 900 representatives of the regional economy, politics, administration and social institutions met yesterday in the Europapark stadium. But it was also about the question: How do we want to shape economic development in these difficult times? Eberhard Liebherr, President of the IHK Südlicher Oberrhein called for staying optimistic right now and moving forward.
How can such a “going forward” look like?
There were a variety of approaches that evening, two of which were discussed on stage:
The first answer came from Holger Stanislawski, a former player and coach at FC St. Pauli and now a supermarket owner. He reported on the legendary FC St. Pauli derby at Hamburger SV in 2011. As FC coach, he switched on the third goalkeeper and initially caused amazement. The plan worked: St. Pauli won against HSV for the first time since 1977.
His conclusion: If you want to be successful, you have to think outside the box, be courageous, and try out new paths. And don't be afraid of failure.
The second half of the IHK home game belonged to the startups
Three startups from the region presented what courageous progress can look like in concrete terms: Bauta, dotscene and Titan. All three can look back on an impressive development that shows: It pays to courageously advance innovations.
For startups there are the best network partners in the region, from social innovation to crafts and life sciences - these had their say after the startups: Malaika Lauk from Baden.Campus, Mona Feist from Black Forest Innovation, Leonard Sporleder from Grünhof and Nikolai Sexauer from Startinsland and Yannick Haldenwanger from StartUp.connect. Peter Neske, Innovation Lead of the Pfizer Healthcare Hub, also reported on how Pfizer advances startups through cooperation.
An inspiring event that also provided a great stage for start-up initiatives, accelerators and startups!
Pfizer Challenge on Adherence in Clinical Studies
"Drugs don't work in patients who don't take them," said C. Everett Coop, former US Surgeon General. A particular problem is non-adherence in clinical studies. The Pfizer Breakthrough Change Accelerator has therefore launched an adherence challenge: New, innovative, patient-friendly solutions are being sought for the continuous improvement of investigational product adherence in clinical studies.
Non-adherence in clinical studies jeopardizes the integrity of the study. Non-adherent study participants can lead to the following results:
- Increased the number of patients required to complete a study
- Increased costs (higher site and patient recruitment)
- Increased time to complete the study
- Increased investigational products overage and associated costs
The Pfizer Breakthrough Accelerator is therefore looking for new, innovative, patient-friendly solutions to continuously improve the adherence of investigational medicinal products in clinical trials. The solution should also allow for the prediction, assessment, and identification of potential risk factors contributing to clinical trial non-adherence in clinical trial participants.
Goals of the challenge
- Solutions that provide support and motivation to remain adherent with investigational products as well as visit schedules throughout their trial
- Provide insights and analytics to better predict the adherence curve for clinical trial participants to allow for appropriate intervention to maintain investigational product adherence.
- Capture adherence metrics back to the study teams
What's in it?
1. Opportunity to participate in a Phase 2 Study
Winners, upon Pfizer’s request, will first negotiate in good faith with Pfizer for the right of Pfizer to develop and/or license Entrant’s solution, including further changes and/or developments made thereof during the Challenge. Funds of up to $200,000 will be paid based on milestones and scope of work. To avoid any doubt, winning the Challenge does not automatically lead to further legally binding contractual agreements with Pfizer. The detailed terms of possible future agreements between Pfizer and the winner (or any of the Entrants) will be negotiated separately and will not be linked to the Term set herein.
2. Mentoring and Guidance
Pfizer experts from various areas are available to the winning team for up to 20 hours of mentoring. Together with the winner, Pfizer will work out the exact needs and goals of the mentoring in order to provide information and to connect the winner with the suitable mentors.
In case you have any questions regarding the Challenge please contact the organizing team at Pfizer under [email protected]More inforation about the challenge
i4Challenge 2022 is now open for applications!
Have you developed innovative solutions, new approaches, next-generation products or services for the digital transformation of Industry 4.0? Then the i4Challenge is the right place for you! SMEs, startups and individuals can apply for the challenge until the end of July.
Focused on innovative solutions, new approaches and next generation products or services for industrial transformation, the i4Challenge offers a platform to help SME’s, startups and Industry 4.0 projects promote their products or services. The ultimate goal of the program is to enable a thriving production technology and industrial innovation ecosystem.
Depending on the stage of the project, applicants can register for one of the two categories "New Idea" or "Innovative Solution".Learn more and apply today
Apply for the "4C Accelerator Tübingen" until July 22!
The "4C Accelerator Tübingen" of Medical Innovations Incubator GmbH is THE qualification program for national and international founders and startups from the medical life science and health sector and includes the focused training in the 4Cs and the Regulatory Thinking® approach. Together with experts, your business model will be further developed and made "investor-ready".
Compared to other industries the survival of life science startups is particularly challenging due to long time periods and the capital requirement until market maturity. This is particularly due to the 4Cs:
- C1 | Commercialization: planning revenue in healthcare system (e.g. reimbursement by insurances)
- C2 | Certification: approval of product & company
- C3 | Clinical Studies: prove evidence of the product
- C4 | Copyright: use data / property rights strategically
The goal of the program
With the program you will be able to answer i.a. the following questions:
- Am I actually developing a medical device and if so, how do I determine this?
- Which norms and standards do I have to consider?
- Do I know the similarities between company certification and product approval?
- What renumeration options does my product have in the health system?
- Is a reimbursement by health insurance companies desirable for my product?
- Is my product attractive for the self-pay market?
Your benefits at a glance:
- Top-class experts: The program works with top-class experts who represent a decisive added value for participating teams. These hold senior positions in industry, are proven subject matter experts or seasoned entrepreneurs which guarantees the appropriate experience and quality of guidance to offer.
- Individual Feedback & Education: During 17 workshop days high-profile external experts will elaborate the 4Cs on the individual needs of each team in sessions that are individually tailored.
- Continuous project management: During 1 year we will guide you in processing the work packages resulting from the 17 workshop days. Progress is discussed in frequent project review meetings and necessary measures are derived.
Who can apply?
Eligible are all national and international students, professionals, founding teams and innovators, including clinicians, nurses, lab technicians, scientists who want to translate their innovative ideas into health solutions of the following domains:
- Medical Devices (gadgets, machines, instruments, implants)
- Therapeutics (drugs, active ingredients)
- Diagnostics (laboratory tests or procedures)
- Digital Health (data, analytics, software, monitoring)
When will the workshop take place?
Date: October 7, 2022 – February 17, 2023, ever Friday, 9am to 5 pm
(except December 23 and 30, January 6)
Format: Online video conference
The working language is English. Individuals and teams can apply until July 22, 2022. The program is funded by the "Start-Up BW" campaign by the Baden-Württemberg Ministry of Economic Affairs, the Stiftung für Medizin-Innovationen and the B. Braun Foundation.Find more information and the application form on the Website of the MII